Company Presentation
GeNeuro SA
| Country: | Switzerland |
| Category: | Clinical Stage Biotech Company |
| Room: | Sydney |
| Date: | 23.04.2024. |
| Time: | 14:15 – 14:30 |
| Website: | www.geneuro.com |
| Speaker: | Jesús Martin Garcia, CEO |
Company profile
GeNeuro is Phase 2 clinical development Swiss company listed on EURONEXT Paris.
GeNeuro is focused on addressing neurodegenerative conditions such as Multiple Sclerosis, Amyotrophic Lateral Sclerosis, and more recently, post COVID neurological syndromes. Its approach is based on neutralizing harmful proteins that can arise from the 8% of human DNA that is of viral origin, known as human endogenous retroviruses (HERVs),
